Stemedica International succeed in a pre-clinical trial to treat Alzheimer’s disease with stem cells
Stemedica International, a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer’s disease…
Stemedica International, a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer’s disease…
Forward Pharma, a biopharmaceutical company focused on a proprietary formulation of dimethyl fumarate for the…
uniQure, a leader in human gene therapy, today announced the acquisition of InoCard GmbH, an…
Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies, a novel…
According to Reuters, Galapagos, a Belgian biotech group announced that GlaxoSmithKline has stopped a joint drug…
Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing…
ProQR Therapeutics is a Netherlands-based biotech company focused on developments of drugs to treat genetic disorders. Daniel…
Active Biotech announced today that its partner Teva Pharmaceutical will initiate a phase II clinical…